BAdvSc (Hons.), PhD
Dr Pinese completed his undergraduate studies at UNSW Australia on the biology of ageing, before moving to the Garvan Institute to pursue cancer research.
At the Garvan Institute, Dr Pinese was a member of the world's largest sequencing effort in pancreatic cancer, and for his work received a PhD on the molecular determinants of survival of patients with pancreatic adenocarcinoma. Dr Pinese then joined the Kinghorn Centre for Clinical Genomics, where he performed rapid-turnaround genomic analysis for cancer patients, and helped to develop Australia's first clinically-accredited whole genome sequencing test for rare disease.
Dr Pinese is currently a Senior Research Officer in Garvan's Genomic Cancer Medicine Lab, where he is the lead analyst for the Medical Genome Reference Bank, and conducts research into the genetic basis of cancer risk.
Cancer Australia Priority-Driven Collaborative Cancer Research Scheme -- Comprehensively surveying the complex genetic determinants of sarcoma risk, 2018
National Computational Infrastructure Merit Allocation Scheme -- A whole genome study to map heritable risk in sarcoma, 2017
Pathfinders Group -- Public lecture: Precision Oncology, 2018
Garvan Institute -- Public lecture: Improving Cancer Treatment Using Genomics, 2018
Probus Club -- Public lecture: Genomics at the Garvan Institute, 2017
Rare Cancers Australia CanForum16 -- Public lecture: Applying New Technologies to Disrupt Cancer, 2016